Trials / Completed
CompletedNCT01102543
Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
Observational Study in Neonatal Intensive Care Units (NICU) on the Real Life Use of Curosurf in Prophylaxis of RDS in Premature Babies.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 972 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 1 Minute – 12 Hours
- Healthy volunteers
- Not accepted
Summary
The aim of Alizé is to describe a population of premature babies (gestational age (GA) \< 32 weeks) in real life situation and the management of RDS.
Detailed description
Description includes gestational age, birth clinical characteristics in particular the respiratory function, evaluation of the mother prenatal corticosteroids treatment in prophylaxis of RDS, mother medical and obstetric history, premature babies care in the delivery room with a special focus on the Curosurf use: prophylactic or curative use / other surfactant / no surfactant. A special focus is on the Prophylactic use.
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-10-01
- Completion
- 2011-03-01
- First posted
- 2010-04-13
- Last updated
- 2012-04-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01102543. Inclusion in this directory is not an endorsement.